FDA Approves NuVasive's Simplify Disc For Two-Level Cervical Total Disc Replacement WASHINGTON (dpa-AFX) - NuVasive, Inc. (NUVA), Tuesday announced that the NuVasive Simplify Cervical Artificial Disc received approval from the U.S. Food and Drug Administration for two-level cervical total disc replacement. 'This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfolio,' said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. 'There is immense surgeon excitement for this latest edition to our cervical offering, and the expanded two-level indication provides greater opportunities to bring the most clinically effective technology in the cTDR market to more patients.'